Articles

Taiji Sakamoto, MD, PhD, spoke about being a board member of EURETINA and his motivations to be a part of the cooperative work that is a hallmark of EURETINA. The interview took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.

The e-poster came in 2nd place for the August Deutman award at the EURETINA Congress

Neltependocel has received both regulatory and reimbursement approval in Japan

Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab

Carl Awh, MD, FASRS, spoke the value of the international community of retina clinicians connecting at global meetings

The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of the EMA's initial response

Stefano Mercuri, MD, speaks about his team's August Deutman award-winning research on retinitis pigmentosa and Rho gene mutations

Clare Bailey, MD, shared data from the multi-country study on faricimab for patients with DME and nAMD

Prof Bodaghi praises the ingenuity at this year's EURETINA Innovation Spotlight (EIS)

Enrico Borrelli, MD, FEBO, speaks about opportunities in the retina space

Challenging surgical videos from the Vit-Buckle Society symposia and data on the impact of home OCT in management of nAMD

The general secretary of the European Society of Retina Specialists (EURETINA) says the future of AI is here

Editorial advisory board member Alexandra Miere, MD, PhD, says oculomics is the next big thing in eye care

Additional previous surgeries and the duration of the SO tamponade had little or no impact

Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial

New research and EURETINA highlights from the director of the "underdog" eye clinic

How retinal imaging can provide clinicians a deeper understanding of myopia

Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"

The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission

Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk

We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA

Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies

Why having a set process for diagnostic imaging is crucial to patient outcomes

Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.

A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies

The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients

Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences

Uncertainty during everyday navigation tasks may adversely affect quality of life for patients with glaucoma

Spotlight on the retina specialists who make up the Eye Care Network advisory boards

Businesses in the retina care space tease new technologies and cutting-edge therapeutics